Andrew S. Fein

Mr. Andrew S.
Fein is a Managing Director & Senior Healthcare Analyst at H.
C.
Wainwright & Co. LLC.
He conducted more than twelve years of biotechnology equity research.
Prior to joining H.C.
Wainwright, Mr. Fein worked as the Head of the Healthcare Research effort at Chardan Capital Markets.
He began his career at J.P.
Morgan H&Q and first gained recognition as a Senior Analyst at Leerink Swann.
After that, Mr. Fein worked as a Managing Director/Senior Biotechnology Analyst at Jefferies, Piper Jaffray and Collins Stewart.
He received his Bachelor of Arts degree from Yale University and a doctorate degree from New York University.